Journal of Drugs in Dermatology articles from October 2003

Journal of Drugs in Dermatology archives from October 2003

Errata.(correction to "Linezolid and quinupristin/dalfopristin: novel antibiotics for gram-positive infections of the skin" in volume 2(4), 378-383, 2003)(Correction Notice)
October 1, 2003... ONE OF THE ARTICLES PUBLISHED IN THE AUGUST 2003 ISSUE OF THE JOURNAL OF DRUGS IN DERMATOLOGY INCORRECTLY OMITTED THE NAMES OF SOME OF THE COAUTHORS. THE CORRECT TITLE, CITATION, AND AUTHORS ARE LISTED BELOW: ERIC S SCHWEIGER MD, NOAH S...

A letter from the guest editor.
October 1, 2003... Dermatologic surgery is a specialty on the rise. In a survey conducted by the American Society for Dermatologic Surgery in 2003, the annual number of dermatologic surgery procedures performed has increased to over 4 million. This is an increase...

Enhancement of the results of neck liposuction with the family technique.
October 1, 2003... Abstract Submental liposuction is an excellent procedure for improving the aging neck by reducing the cervicomental angle and increasing the definition of the mandibular border. However, it does not address the loss of volume of the chin...

Non-surgical radiofrequency facelift.(Articles)
October 1, 2003... Abstract There has been considerable interest in using non-ablative methods to rejuvenate the skin. The ThermaCool TC[TM] (Thermage[R] Inc.) is a radiofrequency (RF) device that has been introduced to induce tightening of the address the...

Photodynamic therapy with topical aminolevulinic acid and pulsed dye laser irradiation for sebaceous hyperplasia.
October 1, 2003... Abstract Successful and long-standing eradication of sebaceous hyperplasia has remained difficult due to the propensity of these lesions to be extensive. Current treatments include excision, electrodesiccation, laser vaporization, and oral...

Long term sterility of fat frozen for up to 24 months.
October 1, 2003... Abstract Fat transfer is most effective when fresh fat is used, with excess fat frozen and saved for touch-ups. The obvious benefit to using frozen fat is that harvesting does not have to be done each time fat is injected. It is important...

Phosphatidylcholine in the treatment of localized fat.
October 1, 2003... Abstract Phosphatidylcholine was initially used in emergencies and in the treatment of atheroma plaques in cardiac diseases. Recently, it has also been used in the treatment of localized fat deposits. We report on the authors' clinical...

Treatment of hyperhidrosis.
October 1, 2003... Abstract Hyperhidrosis, or excessive sweating, is a disorder that may cause social isolation or occupational disability. It may be generalized or localized, and although frequently idiopathic it may be a manifestation of a number of...

Their role in dermatology practice.(Focus On: Cosmeceuticals)
October 1, 2003... Introduction Cosmeceutical skin care products, which fall somewhere between cosmetics and pharmaceuticals, are playing an increasing role in the dermatologist's daily practice (19). These agents contain active ingredients with known and...

Skin cancer sites online: watch out for red flags.
October 1, 2003... A close relative has skin cancer. Your doctor has explained the situation, but you're desperate for more information. So, like 70 million other Americans, you look for medical advice on the Internet. You find a slew of skin cancer sites. The...

Yellow nail pigmentation following depakote therapy.(Case Reports)
October 1, 2003... Abstract Two months after being started on Depakote[R] (divalproex sodium; Abbott Laboratories Inc., Abbott Park, Illinois), a 57-year-old female noticed the development of a transverse yellow band on all 20 proximal nails that eventually...

Nephrogenic fibrosing dermopathy after five days of hemodialysis.(Case Reports)
October 1, 2003... Introduction Nephrogenic fibrosing dermopathy (NFD) is a newly-reported illness associated with renal disease; more specifically, with dialysis. Papules, subcutaneous nodules, and joint contractures are present in the skin. Pathologically,...

Rosacea fulminans associated with pegylated interferon alpha-2b and ribavirin theraphy.(Case Reports)
October 1, 2003... Abstract Rosacea fulminans is characterized by the sudden onset of large, coalescing nodules and draining sinuses on the face. A few reports have linked medications to this condition, but none have described the onset of rosacea fulminans...

Morbilliform drug reaction with histologic features of pustular dermatosis associated with bryostatin-1.(Case Reports)
October 1, 2003... Abstract Bryostatin-1 is a new chemotherapeutic agent that inhibits protein kinase C. The most common side effect and the dose limiting toxicity is myalgia. The cutaneous side effects reported during the phase I and II trials were...

Using rituximab (anti-cd20 antibody) in a patient with paraneoplastic pemphigus.(Case Reports)
October 1, 2003... Abstract Paraneoplastic pemphigus (PNP) is a rare autoimmune mucocutaneous blistering disease that is commonly associated with underlying B-cell neoplasms. There is no standard therapy for PNP. Potent immunosuppression has been the only...

Multiple fixed drug eruption with interferon/ribavirin combination therapy for hepatitis c virus infection.(Case Reports)
October 1, 2003... Abstract Interferon/ribavirin combination therapy is the treatment of choice for chronic hepatitis C virus (HCV) infection. Cutaneous reactions to interferon therapy, both local and distant from the injection site, are not uncommon....

New FDA indication for Humatrope.(Pipeline Previews)(Brief Article)
October 1, 2003... The Food and Drug Administration (FDA) approved a new indication for the growth hormone Humatrope[R] (somatropin) for the long-term treatment of children with idiopathic short stature. Humatrope's new indication for idiopathic short stature is...

FDA approves Enbrel (etanercept) for treatment of rheumatoid arthritis.(Pipeline Previews)
October 1, 2003... Enbrel[R] is a human anti-TNF receptor currently approved for the treatment of psoriatic arthritis. Its approval by the FDA for the alleviation of symptoms in moderate to severe rheumatoid arthritis (RA) marks this drug as the only biologic...

FDA recommends approval of Enbrel (etanercept) for the treatment of ankylosing spondylitis.(Pipeline Previews)(Brief Article)
October 1, 2003... Enbrel[R] (etanercept) is the first biologic agent recommended for approval by the Arthritis Advisory Committee of the U.S. Food and Drug Administration (FDA) for the treatment of ankylosing spondylitis (AS). AS is a chronic inflammatory...

75 mg Adoxa (doxycycline) tablets available in U.S.(Pipeline Previews)
October 1, 2003... Adoxa[R] 75 mg tablets provide dermatologists with greater flexibility in the dosing of doxycycline therapy for the treatment of acne. Adoxa is currently available in 50 and 100 mg tablets. All three Adoxa Tablet strengths are small,...

Updated labeling for Soriatane (acitretin) for psoriasis.(Pipeline Previews)(Brief Article)
October 1, 2003... Soriatane[R] (acitretin), a systemic medication for severe psoriasis, has received approval for an enhanced product labeling. The major changes to the label include: -Information regarding reducing phototherapy dose in patients...

Assessment of adapalene gel for the treatment of actinic keratoses and lentiginess a randomized trial.(Washington Whispers)
October 1, 2003... The purpose of this article was to determine the safety and efficacy of adapalene gel in the treatment of actinic keratoses and solar lentigines. A prospective two-center, randomized, controlled, investigator-masked, parallel-group study...

Treating Bowen's disease: a cost-minimization study.(Washington Whispers)
October 1, 2003... In the current economic climate, it is important to justify the cost of treatments used in dermatology, particularly where cheaper alternatives exist. The purpose of this study is to determine which treatment modality commonly used for...

The nonrandom distribution of facial hemangiomas.(Washington Whispers)(Brief Article)
October 1, 2003... To better understand the growth patterns and pathogenesis of infantile hemangiomas, Waner et al. recently concluded a retrospective analysis of 205 patients diagnosed with facial infantile hemangiomas. Waner and colleagues note that their...

A practical technique for differentiation of sub-epidermal bullous diseases: localization of in vivo-bound IGG by laser scanning confocal microscopy.(Washington Whispers)(Brief Article)
October 1, 2003... The purpose of this study was to develop a practical technique to distinguish autoimmune sub-epidermal bullous diseases.The authors present a prospective study from an academic referral center. The patient population consisted of forty-two...

Efficacy and safety of azelaic acid (15%) gel as a new treatment for papulopustular rosacea: results from two vehicle-controlled, randomized phase III studies.(Washington Whispers)
October 1, 2003... The objective of these studies was to evaluate the efficacy, tolerability, and safety of a new formulation of 15% azelaic acid gel (AzA gel), for the topical treatment of moderate papulopustular rosacea. Two multicenter, double-blind,...

Paroxetine controlled release in the treatment of menopausal hot flashes: a randomized controlled trial.(Washington Whispers)
October 1, 2003... The standard therapy for hot flashes has been hormone replacement (HRT) with estradiol or progestational agents. Recent studies suggest that serotin reuptake inhibitors may also be effective. The authors set to evaluate a selective serotonin...

Suggested guidelines for screening and management of tuberculosis in patients taking oral glucocorticoids--an important but often neglected issue.(Washington whispers)(Brief Article)
October 1, 2003... The authors intend to create an algorithm of the screening and treatment guidelines for tuberculosis patients and adjunct treatment with glucocorticoids. They state systemic glucocorticoids are the mainstay of immunosuppressive therapy for...

Celocoxib in preventing skin cancer in patients with actinic keratoses.(Clinical Trial Review)(Brief Article)
October 1, 2003... This study is currently recruiting patients. Sponsored by UAB Comprehensive Cancer Center, National Cancer Institute (NCI) Chemoprevention therapy involves the use of certain drags to try to prevent the development or recurrence of...

Determine the efficacy of topical tretinoin cream the prevention of nonmelanoma skin cancer.(Clinical Trial Review)(Brief Article)
October 1, 2003... This study is currently recruiting patients. Sponsored by Department of Veterans Affairs Cooperative Studies Program, Ortho Dermatologics In this study, 900 patients with a recent history of squamous cell and/or basal cell carcinoma...

Photodynamic therapy in treating patients with skin cancer.(Clinical Trial Review)(Brief Article)
October 1, 2003... This study is currently recruiting patients. Sponsored by Roswell Park Cancer Institute, National Cancer Institute (NCI) Photodynamic therapy uses light and drugs that make cancer cells more sensitive to light to kill tumor cells....

Phase II randomized study of cultured skin substitutes versus split thickness skin grafts in patients with severe burn injuries.(Clinical Trial Review)(Brief Article)
October 1, 2003... This study is currently recruiting patients. Sponsored by FDA Office of Orphan Products Development, University of Cincinnati This study will determine the safety and efficacy of biosynthetic skin substitute as a routine therapy for...

Photodynamic therapy in treating patients with skin cancer or solid tumors metastatic to the skin.(Clinical Trial Review)(Brief Article)
October 1, 2003... This study is currently recruiting patients. Sponsored by Ireland Cancer Center, National Cancer Institute (NCI) Photodynanric therapy uses light and drugs that make cancer cells more sensitive to light to kill tumor cells. This may be...

Photodynamic therapy in treating patients with basal cell skin cancer.(Clinical trial review)(Brief Article)
October 1, 2003... This study is currently recruiting patients. Sponsored by Roswell Park Cancer Institute, National Cancer Institute (NCI) Photodynamic therapy uses light and drugs that make cancer cells more sensitive to light to kill tumor cells....

Interleukin-12 gene therapy in treating patients with skin metastases.(Clinical Trial Review)(Brief Article)
October 1, 2003... This study is currently recruiting patients. Sponsored by University of Wisconsin Comprehensive Cancer Center, National Cancer Institute (NCI) Inserting tile gene for interleukin-12 into a person's skin tumor cells may make the body...

Two studies to determine if verteporfin PDT is effective & safe in treating multiple basal cell carcinomas of the skin.(Clinical Trial Review)(Brief Article)
October 1, 2003... This study is currently recruiting patients. Sponsored by QLT Inc., Novartis Pharmaceuticals The purpose of the two studies is to determine whether an experimental therapy using a photoactive drug, verteporfin, in combination with...

Celoxib in preventing skin cancer.(Clinical Trial Review)(Brief Article)
October 1, 2003... This study is currently recruiting patients. Sponsored by Herbert Irving Comprehensive Cancer Center, National Cancer Institute (NCI) Celecoxib may be effective in preventing skin cancer by decreasing redness caused by exposure to...

Phase III randomized study of oral acyclovir in infants with herpes simplex virus infection limited to skin, eyes, and mouth.(Clinical Trial Review)(Brief Article)
October 1, 2003... This study is currently recruiting patients. Sponsored by National Center for Research Resources (NCRR), UAB Comprehensive Cancer Center This study is designed to determine the efficacy of long term suppressive therapy with oral...

Topical imiquimod compared with surgery in treating patients with basal cell skin cancer.(Clinical Trial Review)(Brief Article)
October 1, 2003... This study is currently recruiting patients. Sponsored by Cancer Research UK Biological therapies such as imiquimod use different ways to stimulate the immune system and stop cancer ceils from growing. It is not yet known if topical...

Bioengineered skin and wound healing.(Clinical Trial Review)(Brief Article)
October 1, 2003... This study is currently recruiting patients. Sponsored by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) This study will look at whether a graft of bioengineered skin (BSC), known commercially as...

ZD1839 (Iressa[R]) for recurrent or metastatic squamous cell carcinoma of the skin.(Clinical Trial Review)(Brief Article)
October 1, 2003... This study is not yet open for patient recruitment. Sponsored by M.D. Anderson Cancer Center This is a Phase II trial to determine the effectiveness of 250 mg ZD1839 daily by mouth for 6 courses of treatment (1 course = 4 weeks) to...

Photodynamic therapy in treating patiens with skin cancer.(Clinical Trial Review)
October 1, 2003... This study is currently recruiting patients. Sponsored by Roswell Park Cancer Institute Photodynamic therapy uses light and drugs that make cancer cells more sensitive to light to kill tumor cells. Photodynamic therapy using...

To study the effects of CD25 and low-dose cyclosporin in the treatment of active psoriasis Vulgaris.(Clinical Trial Review)(Brief Article)
October 1, 2003... This study is currently recruiting patients. Sponsored by Protein Design Labs This study compares the efficacy and analyzes the cellular effects of anti-TAC (daclizumab) and cyclosporine in the treatment of psoriasis vulgaris. This is...

To study the use of humanized CD25 in preventing the relapse of psoriasis vulgaris.(Clinical Trial Review)(Brief Article)
October 1, 2003... This study is currently recruiting patients. Sponsored by Protein Design Labs

To study disease relapse after NBUVB and how the administration of daclizumab/placebo alters disease relapse.(Clinical Trial Review)(Brief Article)
October 1, 2003... Condition Treatment or Intervention Phase Psoriasis Drug: daclizumab Phase I Phase II Study ID Numbers: JKR-0337 NLM Identifier:...

Phase II trial of allovectin-7[R] for metastatic melanoma.(Clinical Trial Review)(Brief Article)
October 1, 2003... This study is currently recruiting patients. Sponsored by Vical The purpose of this clinical trial is to determine if Allovectin-7(R), an experimental gene-based immunotherapy, can shrink melanoma tumors. The trial will also examine if...

Morphine gel for bedsores.(Clinical Trial Review)(Brief Article)
October 1, 2003... This study is currently recruiting patients. Sponsored by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) This study tests the effectiveness of a morphine-containing gel for reducing pain caused by...

PHASE III randomized study of oral acyclovir in infants with herpes simplex virus infection involving the central nervous system.(Clinical Trial Review)(Brief Article)
October 1, 2003... This study is currently recruiting patients. Sponsored by National Center for Research Resources (NCRR), UAB Comprehensive Cancer Center This study is designed to determine the efficacy of long term suppressive therapy with oral...

Oral acyclovir for neonatal HSV disease of the skin, eyes, and mouth.(Clinical Trial Review)
October 1, 2003... This study is currently recruiting patients. Sponsored by National Institute of Allergy and Infectious Diseases (NIAID) This study tests whether long-term treatment with oral acyclovir improves the outcome for infants with HSV disease...

Vaccine therapy followed by biological in treating patients with stage III or stage IV melanoma.(Clinical Trial Review)
October 1, 2003... This study is currently recruiting patients. Sponsored by University of Southern California, National Cancer Institute (NCI) Vaccines made from melanoma cells may make the body build an immune response to kill tumor cells. Biological...

Celecoxib in preventing basal cell carcinoma in patients with basal cell nevus syndrome.(Clinical Trial Review)
October 1, 2003... This study is currently recruiting patients. Sponsored by University of California at San Francisco, National Cancer Institute (NCI) Chemoprevention therapy is the use of certain drugs to try to prevent the development of cancer. The...

Oral type I collagen in scleroderma.(Brief Article)
October 1, 2003... This study is currently recruiting patients. Sponsored by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) This is a 15-month study to find out if taking type I collagen by mouth will improve diffuse...

Study of Remodulin in patients with critical limb ischemia with no planned revascularization procedures.(Clinical Trial Review)(Brief Article)
October 1, 2003... This study is currently recruiting patients. Sponsored by United Therapeutics This study will assess and compare the safety of continuous and daily subcutaneous Remodulin therapy in patients with critical limb ischemia (CLI) with no...

Radiation therapy in preventing metastatic cancer in patients who have diagnostic procedures to identify malignant mesothelioma.(Clinical Trial Review)(Brief Article)
October 1, 2003... This study is currently recruiting patients. Sponsored by Cancer Research Campaign Clinical Trials Centre Radiation therapy uses high-energy x-rays to damage tumor cells. It is not yet known if radiation therapy is effective in...

Phase II study of ultraviolet A-1 light therapy for systemic lupus erythematosus.(Clinical Trial Review)(Brief Article)
October 1, 2003... This study is currently recruiting patients. Sponsored by National Center for Research Resources (NCRR), Louisiana State University This study will evaluate the mechanisms of ultraviolet A-1 light therapy in patients with systemic...

Long-term treatment and re-treatment of lower extremity diabetic ulcers with Regranex[R] or placebo.(Clinical Trial Review)(Brief Article)
October 1, 2003... This study is currently recruiting patients. Sponsored by Johnson & Johnson Pharmaceutical Research and Development, L.L.C. The purpose of this study is to evaluate the efficacy and safety of Regranex Gel versus placebo when applied to...

Phase II study of high-dose cycloposphamide in patients with refractory pemphigus.(Brief Article)
October 1, 2003... This study is currently recruiting patients. Sponsored by Johns Hopkins Oncology Center This study is designed to determine the response rate and 1-year event-free survival of patients with refractory pemphigus treated with high-dose...

Determine the effect of administering Periostat[R] twice daily on patients with acne rosacea.(Clinical Trial Review)(Brief Article)
October 1, 2003... This study is currently recruiting patients. Sponsored by CollaGenex Pharmaceuticals The purpose of this study is to determine whether Periostat (R) (doxycycline hyclate 20 mg tablets) taken twice daily is effective in reducing the red...

Phase I study of immune ablation and CD34+ peripheral blood stem cell support in patients with systemic lupus erythematosus.(Clinical Trial Review)(Brief Article)
October 1, 2003... This study is currently recruiting patients. Sponsored by Northwestern Memorial Hospital This trial will study the safety of immune ablation with high-dose cyclophosphamide and anti-thymocyte globulin followed by peripheral blood stem...

Study of GL701 in men with systemic lupus erythematosus.(Clinical Trial Review)
October 1, 2003... This study is currently recruiting patients. Sponsored by Genelabs Technologies Lupus flares and other symptoms associated with systemic lupus erythematosus (SLE) may be caused by a deficiency of dehydroepiandrosterone (DHEA), GL701 is...

Aldara[TM] (Imiquimod) Cream to treat basal cell carcinoma.(Clinical Trial Review)(Brief Article)
October 1, 2003... This study is currently recruiting patients. Sponsored by Warren G Magnuson Clinical Center (CC) This study will evaluate the effectiveness of Aldara (TM) (Imiquimod) Cream in treating basal cell carcinoma. Condition ...

Campath-1H for treating adult T-cell leukemia.(Clinical Trial Review)(Brief Article)
October 1, 2003... This study is currently recruiting patients. Sponsored by National Cancer Institute (NCI) Campath-lH (alemtuzumab) is approved by the Food and Drug Administration for treating chronic lymphocytic leukemia. This study will examine the...

Stem cell transplant therapy with campath-1H for treating advanced mycosis fungoides and sezary syndrome.(Clinical Trial Review)(Brief Article)
October 1, 2003... This study is currently recruiting patients. Sponsored by National Heart, Lung, and Blood Institute (NHLB1) This study will investigate the safety and effectiveness of a modified donor stem cell transplantation procedure for treating...

Peptide vaccination for patients at high risk for recurrent melanoma.(Clinical Trial Review)(Brief Article)
October 1, 2003... This study is currently recruiting patients. Sponsored by National Cancer Institute (NCI) This study wiI1 examine the effectiveness and side effects of an experimental vaccine to prevent recurrence of melanoma; the vaccine will be...

Interleukin-12 with either liposomal doxorubicin or 96 hour continuous infusion paclitaxel in AIDS-associated kaposi's sarcoma followed by chronic administration of interleukin-12.(Clinical Trial Review)(Brief Article)
October 1, 2003... This study is currently recruiting patients. Sponsored by National Cancer Institute (NCI) This study will test the safety and effectiveness of combined therapy using liposomal doxorubicin (Doxil) and interleukin-12 (1L12) for treating...

Tyrosinase-related protein (TRP-2) vaccination for metastatic melanoma.(Clinical Trial Review)(Brief Article)
October 1, 2003... This study is currently recruiting patients. Sponsored by National Cancer Institute (NCI) This study will test the safety and effectiveness of an experimental vaccine for fighting metastatic melanoma. The vaccine contains a peptide...

Vaccine plus interleukin-2 treatment of metastatic melanoma.(Clinical Trial Review)(Brief Article)
October 1, 2003... This study is currently recruiting patients. Sponsored by National Cancer Institute (NCI) This study will examine the safety and effectiveness of treatment with an experimental vaccine plus interleukin-2 (IL-2) for melanoma, a type of...

CTLA-4 antibody (MDX-010) plus interleukin-2 to treat advanced melanoma.(Clinical Trial Review)(Brief Article)
October 1, 2003... This study is currently recruiting patients. Sponsored by National Cancer Institute (NCI) This study will determine the highest dose of MDX-010 that can safely be given in conjunction with interleukin2 (IL-2) to patients with advanced...

IL-2 gene therapy for metastatic melanoma.(Clinical Trial Review)(Brief Article)
October 1, 2003... This study is currently recruiting patients. Sponsored by National Cancer Institute (NCI) This study will examine the safety and effectiveness of gene therapy for creating special tumor-fighting cells to treat patients with metastatic...

Gp100 and MDX-CTLA-4 vaccination for stage IV melanoma.(Clinical Trial Review)(Brief Article)
October 1, 2003... This study is currently recruiting patients. Sponsored by National Cancer Institute (NCI) This study will examine the safety and effectiveness of an experimental vaccine given with an immune booster to treat advanced melanoma. The...

Cancer vaccine for lymphoma following chemotherapy.(Clinical Trial Review)(Brief Article)
October 1, 2003... This study is currently recruiting patients. Sponsored by National Cancer Institute (NCI) This study will evaluate the effectiveness of an experimental cancer vaccine for lymphoma. Although currently available lymphoma treatments...

Depsipeptide to treat T-cell lymphomas.(Clinical Trial Review)(Brief Article)
October 1, 2003... This study is currently recruiting patients. Sponsored by National Cancer Institute (NCI) This study will test the safety and effectiveness of a new anticancer drug called depsipeptide in treating T-cell lymphomas. Depsipeptide has...

PS-341 alone and PS-341 plus EPOCH chemotherapy to treat non-Hodgkin's lymphoma.(Clinical Trial Review)(Brief Article)
October 1, 2003... This study is currently recruiting patients. Sponsored by National Cancer Institute (NCI) This study will examine the safety and effectiveness of an experimental drug called PS-341, given alone and in combination with a chemotherapy...

Etanercept to treat Wegener's granulomatosis.(Clinical Trial Review)(Brief Article)
October 1, 2003... This study is currently recruiting patients. Sponsored by National Institute of Allergy and Infectious Diseases (NIAID) The Food and Drug Administration has approved etanercept (also called Enbre(R) or TNFR:Fc) for treating rheumatoid...

Open label study of ONTAK[R] (denileukin diftitox) in previously treated cutaneous T-cell lymphoma patients.(Clinical Trial Review)(Brief Article)
October 1, 2003... This study is currently recruiting patients. Sponsored by Ligand Pharmaceuticals The purpose of this study is to provide an opportunity for patients who exhibit progressive disease while receiving placebo on the companion 93-04-11...

Randomized double-blind study of ONTAK[R] (denileukin diftitox) in cutaneous T-cell lymphoma (CTCL) patients.(Clinical Trial Review)(Brief Article)
October 1, 2003... This study is currently recruiting patients. Sponsored by Ligand Pharmaceuticals The purpose of this study is to compare the effectiveness of two dose levels of ONTAK[R] (denileukin diftitox) in treating patients who have recurrent or...